Author： Escudier Bernard
Publisher： Adis International
ISSN： 1174-5886
Source： Drugs in R&D, Vol.11, Iss.2, 2011-06, pp. : 113-126
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Bracarda Sergio Castellano Daniel Procopio Giuseppe Sepúlveda Juan M Sisani Michele Verzoni Elena Schmidinger Manuela
Expert Opinion on Drug Safety, Vol. 13, Iss. 4, 2014-04 ,pp. :
Access to resources
Recommend
Ramucirumab in metastatic renal cell carcinoma: The beginning or the end?
By Pal Sumanta K. Figlin Robert A.
Cancer, Vol. 120, Iss. 11, 2014-06 ,pp. :
Emerging Targeted Therapies in Metastatic Renal Cell Carcinoma
Current Clinical Pharmacology, Vol. 6, Iss. 3, 2011-08 ,pp. :
Emerging Immunotargets in Metastatic Renal Cell Carcinoma
Current Drug Targets, Vol. 17, Iss. 7, 2016-06 ,pp. :
Systemic Therapies for Metastatic Renal Cell Carcinoma in Older Adults
Drugs & Aging, Vol. 28, Iss. 8, 2011-08 ,pp. :